Ignite Creation Date:
2025-12-25 @ 2:01 AM
Ignite Modification Date:
2026-05-28 @ 6:16 PM
Study NCT ID:
NCT06145360
Status:
COMPLETED
Last Update Posted:
2024-04-08
First Post:
2023-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient
Sponsor:
SINA Health Education and Welfare Trust
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
00003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | UNKNOWN | View |